Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00119652
Other study ID # D1447C00134
Secondary ID
Status Completed
Phase Phase 3
First received July 6, 2005
Last updated January 3, 2013
Start date May 2005
Est. completion date May 2007

Study information

Verified date January 2013
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.


Recruitment information / eligibility

Status Completed
Enrollment 676
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Male and female out-patients aged 18 to 65 years inclusive

- Diagnosis of Bipolar Disorder (Bipolar I or Bipolar II), most recent episode depressed

Exclusion Criteria:

- Current period of depression lasting less than 4 weeks or more than 12 months

- Use of prohibited medication

- Substance or alcohol dependence or abuse

- Current suicide risk or suicide attempt within 6 months

- Breast feeding or pregnancy

- Clinically relevant disease or clinical finding

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Intervention

Drug:
quetiapine fumarate (Seroquel)

paroxetine

Behavioral:
mood stabilizing activity


Locations

Country Name City State
Australia Research Site Brisbane Queensland
Australia Research Site Epping Victoria
Australia Research Site Everton Park Queensland
Australia Research Site Malvern Victoria
Australia Research Site Southport Queensland
Chile Research Site Providencia Santiago
Chile Research Site Santiago
Colombia Research Site Bogota
Costa Rica Research Site San Jose
Greece Research Site Athens
Greece Research Site Thessaloniki
Greece Research Site Tripoli
Mexico Research Site Mexico
Mexico Research Site Yucatan
Peru Research Site Lima
Peru Research Site San Borja
Romania Research Site Bucharest
Romania Research Site Galati
Romania Research Site Iasi
Romania Research Site Magura
South Africa Research Site Benoni
South Africa Research Site Cape Town
South Africa Research Site Durban
South Africa Research Site Pretoria
Turkey Research Site Gaziantep
Turkey Research Site Istanbul
Turkey Research Site Manisa
United States Research Site Atlanta Georgia
United States Research Site Austin Texas
United States Research Site Bellevue Washington
United States Research Site Cincinnati Ohio
United States Research Site Clementon New Jersey
United States Research Site Dallas Texas
United States Research Site Dayton Ohio
United States Research Site Glen Burnie Maryland
United States Research Site Irving Texas
United States Research Site Kirkland Washington
United States Research Site Little Rock Arkansas
United States Research Site Maitland Florida
United States Research Site National City California
United States Research Site New Orleans Louisiana
United States Research Site New York New York
United States Research Site Northfield Illinois
United States Research Site Oak Brook Illinois
United States Research Site Oklahoma City Oklahoma
United States Research Site Philadelphia Pennsylvania
United States Research Site Phoenix Arizona
United States Research Site Raleigh North Carolina
United States Research Site Richmond Virginia
United States Research Site San Clemente California
United States Research Site San Diego California
United States Research Site Shreveport Louisiana
United States Research Site Smyrna Georgia
United States Research Site St. Louis Missouri
United States Research Site Winter Park Florida

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Countries where clinical trial is conducted

United States,  Australia,  Chile,  Colombia,  Costa Rica,  Greece,  Mexico,  Peru,  Romania,  South Africa,  Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline to Week 8 assessment in the total score on the Montgomery-Asberg Depression Rating Scale (MADRS)
Secondary Secondary variables supportive to the primary objective:
Secondary MADRS total score response
Secondary MADRS total score remission
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A